HARROW, INC. — Director's Dealing 2016

Apr 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2016-04-01

Reporting Person: SAHAREK JOHN P. (Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-01	Option - Right to Buy	$3.95	A	60000	Acquired	2026-04-01	Common Stock (60000)	Direct

Footnotes

F1: Represents stock options granted under the Issuer's 2007 Stock Incentive and Awards Plan. The stock options vest in equal quarterly installments over a three year period.